CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Adline Chem Lab Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Adline Chem Lab Ltd
737 Rakanpur Village
Sola Santej Raod, Kalol
Phone: +91 9228003900p:+91 9228003900 AHMEDABAD, 380015  India Ticker: 524604524604
Business Summary
Adline Chem Lab Limited, formerly Kamron Laboratories Limited, is an India-based pharmaceutical company. The Company is operating in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The Company's products for the international market include tablets, capsules and injections. The Company's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Company’s educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer KuldipParekh 3/5/2024 3/5/2024
Company Secretary, Compliance Officer RituSingh 2/3/2024 2/3/2024
Managing Director SarangPathak 3/5/2024 3/5/2024
Non-Executive Non-Independent Director HemantParikh 2/3/2024 2/3/2024
Non-Executive Independent Director Shivani R.Pathak 2/3/2024 2/3/2024

General Information
Number of Employees: 2 (As of 3/31/2023)
Outstanding Shares: 5,850,000 (As of 3/31/2024)
Stock Exchange: BOM
Fax Number: +91 2764286038


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, September 7, 2024